SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001461790-23-000005
Filing Date
2023-02-09
Accepted
2023-02-08 17:51:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 TCRR_13G_20230208.htm SC 13G/A 104640
  Complete submission text file 0001461790-23-000005.txt   106130
Mailing Address 2 BLOOR STREET WEST SUITE 801 TORONTO A6 M4W 3E2
Business Address 2 BLOOR STREET WEST SUITE 801 TORONTO A6 M4W 3E2 416-365-2155
K2 PRINCIPAL FUND, L.P. (Filed by) CIK: 0001461790 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Subject) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90936 | Film No.: 23600295
SIC: 2836 Biological Products, (No Diagnostic Substances)